BACKGROUND: There are no published data regarding fracture risk in type 2 diabetic patients in Korea. In this study, we compared the fracture incidence and risk of osteoporosis of type 2 diabetic female patients with those in a non-diabetic hypertensive cohort. METHODS: The incidence of fracture in a type 2 diabetic cohort was compared with that in a non-diabetic hypertensive cohort over the course of 7 years. Female type 2 diabetic and non-diabetic hypertensive patients who visited Eulji General Hospital outpatient clinic from January 2004 to April 2004 were assigned to the diabetic cohort and the non-diabetic hypertensive cohort, respectively. Surveys on fracture event, use of anti-osteoporosis medications, and bone mineral density were performed. RESULTS: The number of fractures was 88 in the female diabetic cohort (n=1,268, 60.6±11.5 years) and 57 in the female non-diabetic hypertensive cohort (n=1,014, 61.4±11.7 years). The RR in the diabetic cohort was 1.38 (P=0.064; 95% confidence interval [CI], 0.98 to 1.94) when adjusted for age. Diabetic patients with microvascular complications (61.0%) showed a higher RR of 1.81 (P=0.014; 95% CI, 1.13 to 2.92) compared with those without these complications. The prevalence of osteoporosis was comparable between the groups, while use of anti-osteoporosis medication was more common in the diabetic cohort (12.8%) than in the hypertensive cohort (4.5%) (P<0.001). CONCLUSION: In our study, a higher fracture risk was observed in female type 2 diabetics with microvascular complications. Special concern for this risk group is warranted.
BACKGROUND: There are no published data regarding fracture risk in type 2 diabeticpatients in Korea. In this study, we compared the fracture incidence and risk of osteoporosis of type 2 diabetic female patients with those in a non-diabetic hypertensive cohort. METHODS: The incidence of fracture in a type 2 diabetic cohort was compared with that in a non-diabetic hypertensive cohort over the course of 7 years. Female type 2 diabetic and non-diabetic hypertensivepatients who visited Eulji General Hospital outpatient clinic from January 2004 to April 2004 were assigned to the diabetic cohort and the non-diabetic hypertensive cohort, respectively. Surveys on fracture event, use of anti-osteoporosis medications, and bone mineral density were performed. RESULTS: The number of fractures was 88 in the female diabetic cohort (n=1,268, 60.6±11.5 years) and 57 in the female non-diabetic hypertensive cohort (n=1,014, 61.4±11.7 years). The RR in the diabetic cohort was 1.38 (P=0.064; 95% confidence interval [CI], 0.98 to 1.94) when adjusted for age. Diabeticpatients with microvascular complications (61.0%) showed a higher RR of 1.81 (P=0.014; 95% CI, 1.13 to 2.92) compared with those without these complications. The prevalence of osteoporosis was comparable between the groups, while use of anti-osteoporosis medication was more common in the diabetic cohort (12.8%) than in the hypertensive cohort (4.5%) (P<0.001). CONCLUSION: In our study, a higher fracture risk was observed in female type 2 diabetics with microvascular complications. Special concern for this risk group is warranted.
Entities:
Keywords:
Diabetes mellitus, type 2; Fracture; Osteoporosis
Authors: Elsa S Strotmeyer; Jane A Cauley; Ann V Schwartz; Michael C Nevitt; Helaine E Resnick; Douglas C Bauer; Frances A Tylavsky; Nathalie de Rekeneire; Tamara B Harris; Anne B Newman Journal: Arch Intern Med Date: 2005-07-25
Authors: Ann V Schwartz; Patrick Garnero; Teresa A Hillier; Deborah E Sellmeyer; Elsa S Strotmeyer; Kenneth R Feingold; Helaine E Resnick; Frances A Tylavsky; Dennis M Black; Steven R Cummings; Tamara B Harris; Douglas C Bauer Journal: J Clin Endocrinol Metab Date: 2009-04-21 Impact factor: 5.958
Authors: L Joseph Melton; B Lawrence Riggs; Cynthia L Leibson; Sara J Achenbach; Jon J Camp; Mary L Bouxsein; Elizabeth J Atkinson; Richard A Robb; Sundeep Khosla Journal: J Clin Endocrinol Metab Date: 2008-09-16 Impact factor: 5.958
Authors: Kwang Joon Kim; Yong-Ki Min; Jung-Min Koh; Yoon-Sok Chung; Kyoung Min Kim; Dong-Won Byun; In Joo Kim; Mikyung Kim; Sung-Soo Kim; Kyung Wan Min; Ki Ok Han; Hyoung Moo Park; Chan Soo Shin; Sung Hee Choi; Jong Suk Park; Dong Jin Chung; Ji Oh Mok; Hong Sun Baek; Seong-Hwan Moon; Yong Soo Kim; Sung-Kil Lim Journal: Yonsei Med J Date: 2014-04-01 Impact factor: 2.759